TKM-Ebola approved by the U.S FDA


After the use of the experimental drug Zmapp on two US workers in Liberia, the U.S Food and Drug Administration (FDA) has to a limited extent approved a second meditation. The drug TKM-Ebola has been approved from the next phase of clinical trials.
Read more Second experimental ebola drug gains approval.

Comments

Popular posts from this blog

Man Utd have opened contract talks with David De Gea - BBC Sport

The all new Toyota Mirai